Towards Biomanufacturing of Cell-Derived Matrices
Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tai...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9f023db645c48698034525e98ae8760 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e9f023db645c48698034525e98ae8760 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e9f023db645c48698034525e98ae87602021-11-11T17:20:41ZTowards Biomanufacturing of Cell-Derived Matrices10.3390/ijms2221119291422-00671661-6596https://doaj.org/article/e9f023db645c48698034525e98ae87602021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11929https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tailored for intended applications by carefully optimising the cell sources, culturing conditions and decellularising methods. This unique advantage has inspired the increasing use of CDM for biomedical research, ranging from stem cell niches to disease modelling and regenerative medicine. However, while much effort is spent on extracting different types of CDM and exploring their utilisation, little is spent on the scale-up aspect of CDM production. The ability to scale up CDM production is essential, as the materials are due for clinical trials and regulatory approval, and in fact, this ability to scale up should be an important factor from the early stages. In this review, we first introduce the current CDM production and characterisation methods. We then describe the existing scale-up technologies for cell culture and highlight the key considerations in scaling-up CDM manufacturing. Finally, we discuss the considerations and challenges faced while converting a laboratory protocol into a full industrial process. Scaling-up CDM manufacturing is a challenging task since it may be hindered by technologies that are not yet available. The early identification of these gaps will not only quicken CDM based product development but also help drive the advancement in scale-up cell culture and ECM extraction.Weng Wan ChanFang YuQuang Bach LeSixun ChenMarcus YeeDeepak ChoudhuryMDPI AGarticlecell-derived matricesextracellular matrixdecellularised extracellular matrixbiomaterialshydrogelsbiomanufacturingBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11929, p 11929 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cell-derived matrices extracellular matrix decellularised extracellular matrix biomaterials hydrogels biomanufacturing Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
cell-derived matrices extracellular matrix decellularised extracellular matrix biomaterials hydrogels biomanufacturing Biology (General) QH301-705.5 Chemistry QD1-999 Weng Wan Chan Fang Yu Quang Bach Le Sixun Chen Marcus Yee Deepak Choudhury Towards Biomanufacturing of Cell-Derived Matrices |
description |
Cell-derived matrices (CDM) are the decellularised extracellular matrices (ECM) of tissues obtained by the laboratory culture process. CDM is developed to mimic, to a certain extent, the properties of the needed natural tissue and thus to obviate the use of animals. The composition of CDM can be tailored for intended applications by carefully optimising the cell sources, culturing conditions and decellularising methods. This unique advantage has inspired the increasing use of CDM for biomedical research, ranging from stem cell niches to disease modelling and regenerative medicine. However, while much effort is spent on extracting different types of CDM and exploring their utilisation, little is spent on the scale-up aspect of CDM production. The ability to scale up CDM production is essential, as the materials are due for clinical trials and regulatory approval, and in fact, this ability to scale up should be an important factor from the early stages. In this review, we first introduce the current CDM production and characterisation methods. We then describe the existing scale-up technologies for cell culture and highlight the key considerations in scaling-up CDM manufacturing. Finally, we discuss the considerations and challenges faced while converting a laboratory protocol into a full industrial process. Scaling-up CDM manufacturing is a challenging task since it may be hindered by technologies that are not yet available. The early identification of these gaps will not only quicken CDM based product development but also help drive the advancement in scale-up cell culture and ECM extraction. |
format |
article |
author |
Weng Wan Chan Fang Yu Quang Bach Le Sixun Chen Marcus Yee Deepak Choudhury |
author_facet |
Weng Wan Chan Fang Yu Quang Bach Le Sixun Chen Marcus Yee Deepak Choudhury |
author_sort |
Weng Wan Chan |
title |
Towards Biomanufacturing of Cell-Derived Matrices |
title_short |
Towards Biomanufacturing of Cell-Derived Matrices |
title_full |
Towards Biomanufacturing of Cell-Derived Matrices |
title_fullStr |
Towards Biomanufacturing of Cell-Derived Matrices |
title_full_unstemmed |
Towards Biomanufacturing of Cell-Derived Matrices |
title_sort |
towards biomanufacturing of cell-derived matrices |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/e9f023db645c48698034525e98ae8760 |
work_keys_str_mv |
AT wengwanchan towardsbiomanufacturingofcellderivedmatrices AT fangyu towardsbiomanufacturingofcellderivedmatrices AT quangbachle towardsbiomanufacturingofcellderivedmatrices AT sixunchen towardsbiomanufacturingofcellderivedmatrices AT marcusyee towardsbiomanufacturingofcellderivedmatrices AT deepakchoudhury towardsbiomanufacturingofcellderivedmatrices |
_version_ |
1718432152587075584 |